NCT01709747View on ClinicalTrials.gov

Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration

PHASE3CompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Chronic Pain
Interventions
DRUG

Hydromorphone Hydrochloride

Opioid for chronic pain

DEVICE

Programmable Implantable pump

"Device: Programmable Implantable pump~Programmable Implantable pump delivering intrathecal hydromorphone"

Trial Locations (1)

27103

The Center for Clinical Research, Winston-Salem

All Listed Sponsors
lead

Piramal Critical Care, Ltd.

INDUSTRY

NCT01709747 - Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration | Biotech Hunter | Biotech Hunter